tiprankstipranks
Advertisement
Advertisement

DE:NOVA Stock Latest News

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%
The FlyCboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%
15h ago
NVO
Novo Nordisk Lifts 2026 Guidance as Wegovy Pill Drives Q2 Obesity Growth
PremiumCompany Announcements
Novo Nordisk Lifts 2026 Guidance as Wegovy Pill Drives Q2 Obesity Growth
2d ago
6K
NVO
Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results
PremiumCompany Announcements
Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results
2d ago
6K
NVO
Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER
PremiumThe Fly
Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER
2d ago
NVO
Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%
PremiumThe Fly
Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%
2d ago
NVO
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
PremiumCompany AnnouncementsNovo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
2d ago
6K
NVO
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
Premium
The Fly
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
3d ago
L
TT
Monte Rosa Therapeutics price target lowered to $27 from $37 at Wedbush
Premium
The Fly
Monte Rosa Therapeutics price target lowered to $27 from $37 at Wedbush
3d ago
NVO
GLUE
Novo Nordisk sees optimism as Wegovy pill leads against Foundayo, Reuters says
PremiumThe Fly
Novo Nordisk sees optimism as Wegovy pill leads against Foundayo, Reuters says
3d ago
NVO
NVO Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NVO Earnings this Week: How Will it Perform?
3d ago
NVO
Novo Nordisk: Neutral Rating Maintained as Obesity Franchise Faces GLP‑1 Competition and Shares Trade Near DKK 350 Target
PremiumRatings
Novo Nordisk: Neutral Rating Maintained as Obesity Franchise Faces GLP‑1 Competition and Shares Trade Near DKK 350 Target
3d ago
NVO
Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback
PremiumThe Fly
Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback
6d ago
NVO
BIOA
BioAge Labs price target lowered to $25 from $36 at Roth Capital
PremiumThe FlyBioAge Labs price target lowered to $25 from $36 at Roth Capital
6d ago
NVO
BIOA
Monte Rosa Therapeutics price target lowered at Jefferies after Novo trial miss
Premium
The Fly
Monte Rosa Therapeutics price target lowered at Jefferies after Novo trial miss
6d ago
NVO
GLUE
BioAge Labs pullback after ZEUS data ‘seems overdone,’ says Citi
Premium
The Fly
BioAge Labs pullback after ZEUS data ‘seems overdone,’ says Citi
6d ago
NVO
BIOA
BioAge Labs price target lowered at Jefferies after Novo trial miss
PremiumThe Fly
BioAge Labs price target lowered at Jefferies after Novo trial miss
6d ago
NVO
BIOA
Unusually active option classes on open July 31st
PremiumThe Fly
Unusually active option classes on open July 31st
6d ago
CCL
NVO
Novo Nordisk’s ZEUS Trial Finds No Cardiovascular Event Reduction With Ziltivekimab
PremiumCompany Announcements
Novo Nordisk’s ZEUS Trial Finds No Cardiovascular Event Reduction With Ziltivekimab
6d ago
6K
NVO
Video: Amazon jumps after strongest cloud growth in more than four years
PremiumThe Fly
Video: Amazon jumps after strongest cloud growth in more than four years
6d ago
CVX
NVO
Novo Nordisk reports ziltivekimab did not yield MACE benefits in ZEUS study
PremiumThe FlyNovo Nordisk reports ziltivekimab did not yield MACE benefits in ZEUS study
6d ago
NVO
Novo Nordisk down 10% after ZEUS cardiovascular outcomes study misses goal
Premium
The Fly
Novo Nordisk down 10% after ZEUS cardiovascular outcomes study misses goal
6d ago
NVO
Novo Nordisk Boosts Treasury Stock as 2026 Share Buyback Passes DKK 7.1 Billion
Premium
Company Announcements
Novo Nordisk Boosts Treasury Stock as 2026 Share Buyback Passes DKK 7.1 Billion
10d ago
6K
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >